Literature DB >> 34732544

Association of Reproductive History With Brain MRI Biomarkers of Dementia Risk in Midlife.

Eva Schelbaum1, Lacey Loughlin1, Steven Jett1, Cenai Zhang1, Grace Jang1, Niharika Malviya1, Hollie Hristov1, Silky Pahlajani1, Richard Isaacson1, Jonathan P Dyke1, Hooman Kamel1, Roberta Diaz Brinton1, Lisa Mosconi2.   

Abstract

BACKGROUND AND OBJECTIVES: To examine associations between indicators of estrogen exposure from women's reproductive history and brain MRI biomarkers of Alzheimer disease (AD) in midlife.
METHODS: We evaluated 99 cognitively normal women 52 ± 6 years of age and 29 men 52 ± 7 years of age with reproductive history data, neuropsychological testing, and volumetric MRI scans. We used multiple regressions to examine associations among reproductive history indicators, voxel-wise gray matter volume (GMV), and memory and global cognition scores, adjusting for demographics and midlife health indicators. Exposure variables were menopause status, age at menarche, age at menopause, reproductive span, hysterectomy status, number of children and pregnancies, and use of menopause hormonal therapy (HT) and hormonal contraceptives (HC).
RESULTS: All menopausal groups exhibited lower GMV in AD-vulnerable regions compared to men, with perimenopausal and postmenopausal groups also exhibiting lower GMV in temporal cortex compared to the premenopausal group. Reproductive span, number of children and pregnancies, and use of HT and HC were positively associated with GMV, chiefly in temporal cortex, frontal cortex, and precuneus, independent of age, APOE ε4 status, and midlife health indicators. Although reproductive history indicators were not directly associated with cognitive measures, GMV in temporal regions was positively associated with memory and global cognition scores. DISCUSSION: Reproductive history events signaling more estrogen exposure such as premenopausal status, longer reproductive span, higher number of children, and use of HT and HC were associated with larger GMV in women in midlife. Further studies are needed to elucidate sex-specific biological pathways through which reproductive history influences cognitive aging and AD risk.
© 2021 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34732544      PMCID: PMC8665431          DOI: 10.1212/WNL.0000000000012941

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  50 in total

Review 1.  Voxel-based morphometry--the methods.

Authors:  J Ashburner; K J Friston
Journal:  Neuroimage       Date:  2000-06       Impact factor: 6.556

Review 2.  Menopause across cultures: a review of the evidence.

Authors:  C M Obermeyer
Journal:  Menopause       Date:  2000 May-Jun       Impact factor: 2.953

3.  Parity, number of pregnancies, and the age of onset of Alzheimer's disease.

Authors:  Tomasz Sobow; Iwona Kloszewska
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2004       Impact factor: 2.198

4.  Timing of hormone therapy and dementia: the critical window theory revisited.

Authors:  Rachel A Whitmer; Charles P Quesenberry; Jufen Zhou; Kristine Yaffe
Journal:  Ann Neurol       Date:  2010-11-12       Impact factor: 10.422

5.  Measuring indices of lifelong estrogen exposure: self-report reliability.

Authors:  C Lord; A Duchesne; J C Pruessner; S J Lupien
Journal:  Climacteric       Date:  2009-10       Impact factor: 3.005

Review 6.  Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses.

Authors:  Lars Bertram; Rudolph E Tanzi
Journal:  Nat Rev Neurosci       Date:  2008-10       Impact factor: 34.870

Review 7.  Sex differences in Alzheimer disease - the gateway to precision medicine.

Authors:  Maria Teresa Ferretti; Maria Florencia Iulita; Enrica Cavedo; Patrizia Andrea Chiesa; Annemarie Schumacher Dimech; Antonella Santuccione Chadha; Francesca Baracchi; Hélène Girouard; Sabina Misoch; Ezio Giacobini; Herman Depypere; Harald Hampel
Journal:  Nat Rev Neurol       Date:  2018-08       Impact factor: 42.937

8.  Menstrual cycle and hormonal contraceptive use modulate human brain structure.

Authors:  Belinda Pletzer; Martin Kronbichler; Markus Aichhorn; Jürgen Bergmann; Gunther Ladurner; Hubert H Kerschbaum
Journal:  Brain Res       Date:  2010-06-13       Impact factor: 3.252

Review 9.  Sex and Gender Driven Modifiers of Alzheimer's: The Role for Estrogenic Control Across Age, Race, Medical, and Lifestyle Risks.

Authors:  Aneela Rahman; Hande Jackson; Hollie Hristov; Richard S Isaacson; Nabeel Saif; Teena Shetty; Orli Etingin; Claire Henchcliffe; Roberta Diaz Brinton; Lisa Mosconi
Journal:  Front Aging Neurosci       Date:  2019-11-15       Impact factor: 5.750

10.  Menopause impacts human brain structure, connectivity, energy metabolism, and amyloid-beta deposition.

Authors:  Lisa Mosconi; Valentina Berti; Jonathan Dyke; Eva Schelbaum; Steven Jett; Lacey Loughlin; Grace Jang; Aneela Rahman; Hollie Hristov; Silky Pahlajani; Randolph Andrews; Dawn Matthews; Orli Etingin; Christine Ganzer; Mony de Leon; Richard Isaacson; Roberta Diaz Brinton
Journal:  Sci Rep       Date:  2021-06-09       Impact factor: 4.379

View more
  5 in total

Review 1.  Ovarian steroid hormones: A long overlooked but critical contributor to brain aging and Alzheimer's disease.

Authors:  Steven Jett; Eva Schelbaum; Grace Jang; Camila Boneu Yepez; Jonathan P Dyke; Silky Pahlajani; Roberta Diaz Brinton; Lisa Mosconi
Journal:  Front Aging Neurosci       Date:  2022-07-19       Impact factor: 5.702

2.  Sex- and age-specific associations between cardiometabolic risk and white matter brain age in the UK Biobank cohort.

Authors:  Sivaniya Subramaniapillai; Sana Suri; Claudia Barth; Ivan I Maximov; Irene Voldsbekk; Dennis van der Meer; Tiril P Gurholt; Dani Beck; Bogdan Draganski; Ole A Andreassen; Klaus P Ebmeier; Lars T Westlye; Ann-Marie G de Lange
Journal:  Hum Brain Mapp       Date:  2022-04-23       Impact factor: 5.399

3.  Associations of Parity With Change in Global Cognition and Incident Cognitive Impairment in Older Women.

Authors:  Rui Zhou; Hua-Min Liu; Lian-Wu Zou; Hong-Xia Wei; Yi-Ning Huang; Qi Zhong; Shan-Yuan Gu; Ming-Feng Chen; Shao-Li Wang; Hai-Xia Sun; Xian-Bo Wu
Journal:  Front Aging Neurosci       Date:  2022-05-04       Impact factor: 5.702

Review 4.  Endogenous and Exogenous Estrogen Exposures: How Women's Reproductive Health Can Drive Brain Aging and Inform Alzheimer's Prevention.

Authors:  Steven Jett; Niharika Malviya; Eva Schelbaum; Grace Jang; Eva Jahan; Katherine Clancy; Hollie Hristov; Silky Pahlajani; Kellyann Niotis; Susan Loeb-Zeitlin; Yelena Havryliuk; Richard Isaacson; Roberta Diaz Brinton; Lisa Mosconi
Journal:  Front Aging Neurosci       Date:  2022-03-09       Impact factor: 5.750

Review 5.  Roles of traditional chinese medicine regulating neuroendocrinology on AD treatment.

Authors:  Chujun Deng; Huize Chen; Zeyu Meng; Shengxi Meng
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-21       Impact factor: 6.055

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.